லேபராஸ்கோபிக் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from லேபராஸ்கோபிக். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In லேபராஸ்கோபிக் Today - Breaking & Trending Today
SAN FRANCISCO, Aug. 18, 2021 /PRNewswire/ The global laparoscopic devices market size is anticipated to reach USD 10.8 billion by 2028, expanding at a CAGR of 6.7%, according to a new report ....
Representative image MUMBAI: After blood clots in the arteries of limbs, heart and brain, Covid patients are coming with intestinal clots and gangrene. Across city hospitals, nearly a dozen cases have been treated by physicians and surgeons, who caution that complaints of excruciating and unexplained stomach pain should be investigated. Sunil Gavali is one recent case treated at Andheri’s Holy Family Hospital, in which doctors detected a Covid-induced clot in the intestine. The 58-year-old had come to the emergency ward with severe abdominal pain after a meal. The man, an OT staffer at the same hospital, was vaccinated with both doses of Covishield, and there were no usual Covid red flags. When Gavali’s pain didn’t subside with medications, doctors did a CT scan which showed multiple clots in the main artery supplying blood to the intestine, called mesenteric superior. ....
Laparoscopic Instruments Market worth $22.1 billion by 2026 - Exclusive Report by MarketsandMarkets Laparoscopic Instruments Market by Product (Laparoscope, Insufflator, Suction/Irrigation systems, Access & Energy Devices), Application (Gynecology, General, Urology, Colorectal, Bariatric, Pediatric), End User (Hospital, ASC) - Global Forecast to 2026 , published by MarketsandMarkets, the global market is expected to reach USD 22.1 billion by 2026 from an estimated USD 12.3 billion in 2021, at a CAGR of 12.5%. Browse in-depth TOC on Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=130019497 The Growth in the market is largely driven by the increasing adoption of minimally invasive surgeries over open surgeries, the rising prevalence of colorectal cancer, the increasing number of laparoscopic bariatric procedures, and technological advancements in laparoscopy. On the other hand, reduced Medicare payments to healthcare providers in ....
(2) IRVINE, Calif., Feb. 16, 2021, a California-based technology company known for its ORLenz surgery augmented reality (AR) headset, and the OR-Bot Surgery Visualization Theatre, has announced that they are expanding from external visualization augmented reality (AR) and extended reality (XR) techniques to a first-of-class laparoscopic visualization key-hole instrument called Scopetrx , a Wireless Laparoscopic Swivel Camera Tool. The instrument s mobilization allows the surgeon to have an unobstructed rotating 360° x 270° view with a dramatically increased field-of-view (FoV) of 100 degrees and enhanced 4K resolution. The patent pending wireless real-time video innovation was developed by Ocutrx in conjunction with Dr. David L. Street, M.D., F.A.C.S., a vascular surgeon, and member of the Ocutrx International Surgical Steering Committee. Dr. Street, who is a part of the Oregon Surgical Specialist practice in Medford, Oregon, is board certified for General Surgery and Vasc ....
Australia, a world-renowned surgical robotics market, introduces first Versius system ·Australia becomes the fifth global market to introduce Versius, following approval from the Therapeutic Goods Administration for use in general, gynaecological and urologic laparoscopic surgical procedures. ·The system has been introduced into Macquarie University Hospital in Sydney with Australia joining a number of leading hospitals across Europe and India to adopt this new technology. CAMBRIDGE, United Kingdom. 5 February 2021, 00:01 (GMT). CMR Surgical (CMR), in partnership with LifeHealthcare, today announced the launch of its Versius® Surgical Robotic System in Australia. Macquarie University Hospital – a leading private teaching hospital based in Sydney – is the first to use the system following approval from the Australian Therapeutic Goods Administration (TGA) in late 2019, which allows Versius to be used in a broad range of laparoscopic (minimal access or keyhol ....